OpenBench and Tavros Therapeutics Announce Collaboration to Pursue First-in-class Cancer Target

/PRNewswire/ -- Tavros Therapeutics, a privately held biotechnology company discovering first-in-class cancer therapies, and OpenBench, an emerging leader in...

Related Keywords

North Carolina ,United States ,James Yoder ,Eoin Mcdonnell ,Jim Thompson ,Openbench Inc , ,Hemoshear Therapeutics ,Openbench Tavros Therapeutics ,